1
Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder
Condition(s):Insomnia DisorderLast Updated:January 18, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Insomnia DisorderLast Updated:January 18, 2020Completed
Condition(s):InsomniaLast Updated:April 3, 2008Completed
Condition(s):Adverse EffectsLast Updated:March 27, 2012Completed
Condition(s):Dementia; Depression; Schizophrenia; Psychosomatic Disorders; Anxiety DisordersLast Updated:February 28, 2018Terminated
Condition(s):Chronic InsomniaLast Updated:November 30, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.